|drug424||Inhaled nitric oxide gas Wiki||1.00|
|drug297||Experimental: Questionnaire without precaution information Wiki||1.00|
|drug670||Questionnaire with precaution information Wiki||1.00|
|D003141||Communicable Diseases NIH||0.12|
|D045169||Severe Acute Respiratory Syndrome NIH||0.07|
|D018352||Coronavirus Infections NIH||0.06|
There is one clinical trial.
Thousands of healthcare workers have been infected with SARS-CoV-2 and contracted COVID-19 despite their best efforts to prevent contamination. No proven vaccine is available to protect healthcare workers against SARS-CoV-2. This study will enroll 470 healthcare professionals dedicated to care for patients with proven SARS-CoV-2 infection. Subjects will be randomized either in the observational (control) group or in the inhaled nitric oxide group. All personnel will observe measures on strict precaution in accordance with WHO and the CDC regulations.
Description: Percentage of subjects with COVID-19 diagnosis in the two groupsMeasure: COVID-19 diagnosis Time: 14 days
Description: Percentage of subjects with a positive test in the two groupsMeasure: Positive SARS-CoV-2 rt-PCR test Time: 14 days
Description: Mean/ Median in the two groupsMeasure: Total number of quarantine days Time: 14 days
Description: Percentage in the two groupsMeasure: Proportion of healthcare providers requiring quarantine Time: 14 days